UPCC 27216 Identification and Analysis of Hereditary Gastrointestinal Cancer and Polyposis Syndromes

Enrolling By Invitation
99 years or below
All
Phase N/A
99999 participants needed
1 Location

Brief description of study

The overall objectives of this study focus on patients with either a personal or family history of gastrointestinal cancer, a hereditary gastrointestinal cancer susceptibility syndrome, and/or a gastrointestinal polyposis syndrome, and include: 1. Consent patients for genetic testing if genetic testing is deemed appropriate by the Cancer Risk Evaluation Program at UPHS after review of the patient's personal and family history. 2. Consent patients for inclusion into a registry entitled "Gastrointestinal Cancer and Polyposis Registry." This study includes a consent for genetic testing as well as for inclusion into a patient registry, therefore no outcome variables will be measured in this study. Any subsequent clinical study on the registry participants will necessitate additional IRB approval. N/A.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

Updated on 22 Apr 2026. Study ID: 16-0245
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Abramson Cancer Center Navigator